← All quick references
ClearRounds Health · Cardiology · Quick Reference
Cardiomyopathy Overview: Dilated, Hypertrophic, Restrictive
PDF coming soon
Heart Failure & CardiomyopathyIntermediateIn progressOne-page PDF
Compare DCM, HCM, and restrictive cardiomyopathy with causes, echo clues, workup, treatment, and referral triggers.
Combines dilated, hypertrophic, and restrictive cardiomyopathy on one comparison sheet.
Last reviewed
Pending initial clinical review
Sources / guidelines to verify
- 2024 AHA/ACC HCM Guideline
- 2022 AHA/ACC/HFSA Heart Failure Guideline
Disclaimer: Educational reference only. Not a substitute for clinician judgment, local protocols, or current guideline review.
One-page reference
Draft content pending the site owner’s clinical review. Verify against the sources above and local protocol before clinical use.
1
What it is / why it matters
- Diseases of heart muscle. Three classic phenotypes: dilated (DCM), hypertrophic (HCM), and restrictive (RCM).
- Phenotype guides workup, treatment, family screening, and sudden-death risk assessment.
2
Compare the three
| Feature | DCM | HCM | RCM |
|---|---|---|---|
| Ejection fraction | Reduced | Usually preserved | Preserved / near-normal |
| Hallmark | Dilated LV, systolic dysfunction | Asymmetric septal hypertrophy, SAM, LVOT obstruction | Stiff ventricle, impaired filling, biatrial enlargement |
| Common causes | Idiopathic, ischemic, genetic, alcohol, tachycardia-mediated, peripartum, myocarditis | Sarcomere gene mutations (autosomal dominant) | Amyloid, sarcoid, hemochromatosis, radiation, fibrosis |
| Key risks | HF, arrhythmia, SCD | SCD (esp. young/athletes), AF, HF | HF, AF, conduction disease |
3
Diagnostic clues & workup
- Echocardiography is first-line; cardiac MRI adds tissue characterization (fibrosis, infiltration).
- HCM: murmur intensifies with Valsalva/standing (less preload); screen for LVOT obstruction.
- RCM: look for infiltrative disease — suspect amyloid with LVH + low ECG voltage + neuropathy → PYP scan and serum/urine free light chains.
- Genetic testing and first-degree relative screening for HCM and many DCM cases.
4
Management framework
DCM
- Full HFrEF GDMT (see HFrEF reference); treat the underlying cause
- ICD/CRT by EF and risk after GDMT optimization
HCM
- Avoid dehydration and arterial vasodilators if obstructive
- Beta-blocker or verapamil; disopyramide or a cardiac myosin inhibitor (e.g., mavacamten) for obstructive symptoms
- SCD risk stratification for ICD; septal reduction (myectomy/alcohol ablation) for refractory obstruction; activity counseling
RCM
- Treat the underlying disease (e.g., disease-specific amyloid therapy)
- Cautious diuresis for congestion; manage AF and conduction disease
5
Red flags / escalate now
- HCM with syncope, exertional symptoms, or a family history of sudden death → urgent risk stratification.
- New high-grade conduction disease with HF → consider infiltrative disease (sarcoid/amyloid).
6
Clinic pearls
- HCM is a leading cause of sudden cardiac death in young athletes.
- A preserved EF does not mean a normal heart — HCM and RCM both cause symptoms with normal EF.
- Suspect cardiac amyloidosis in "HFpEF" with LVH, low voltage, bilateral carpal tunnel, or neuropathy.
7
Sources to verify
- 2024 AHA/ACC Hypertrophic Cardiomyopathy Guideline
- 2022 AHA/ACC/HFSA Heart Failure Guideline
- 2023 ACC ECDP on Cardiac Amyloidosis
Related quick references
Suggest an edit or request this reference
Spot something to improve, or want this one-pager prioritized? Send feedback to the ClearRounds Health team.
Share feedback →